358570.KQ
GI Innovation, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 7,620.00
−5.93%Year over year
Reported trailing growth
- Revenue
- +1526.8%
- EBITDA
- -25.9%
- EBIT
- +7.1%
- EPS
- +44.9%
- Free cash flow
- +9.9%
- Operating cash flow
- +17.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +18.6%
- EBITDA
- +29.6%
- EBIT
- +14.3%
- Net income
- +40.2%
- EPS
- +50.7%
- Free cash flow
- +8.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026